Action 1701 CHINA CHEMICAL & PHARMACEUTICAL CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues China Chemical & Pharmaceutical Co., Ltd.

Actions

1701

TW0001701001

Cours en clôture Taiwan S.E.
Autres places de cotation
 00:00:00 18/06/2024 		Varia. 5j. Varia. 1 janv.
22,65 TWD +0,22 % Graphique intraday de China Chemical & Pharmaceutical Co., Ltd. +0,67 % -6,98 %
28/05 China Chemical & Pharmaceutical Co. annonce que Cenra Inc. nomme Wang Hsieh, I-Chen au poste de president du conseil d'administration, a compter du 2 septembre 2024 CI
15/05 China Chemical & Pharmaceutical Co. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
China Chemical & Pharmaceutical Co., Ltd. Announces Cenra Inc Appoints Wang Hsieh, I-Chen as Chairman of the Board of Directors, Effective September 2, 2024
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
China Chemical & Pharmaceutical Co., Ltd. Proposes Dividend Distribution for the Year Ended December 31, 2023
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
China Chemical & Pharmaceutical Co., Ltd. Approves Cash Dividend, Payable on August 22, 2023
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
China Chemical & Pharmaceutical Co., Ltd. Proposes Dividend Distribution for the Fiscal Year 2022
China Chemical & Pharmaceutical Co., Ltd. announced a financing transaction
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
China Chemical & Pharmaceutical : To announce that 2022Q2 Consolidated Financial Statements reported to the Board of Directors.
Megapro Biomedical Co., Ltd, China Chemical & Pharmaceutical Co., Ltd. and Wellbridge Biotech Ltd. Jointly Establishes an Inhalation Dosage Form Company
MegaPro Biomedical, Two Others Form Non-Invasive Drug Development JV
China Chemical & Pharmaceutical : Announcement to correct the details of disclosure of endorsement guarantee information from March 2010 to May 2011
China Chemical & Pharmaceutical : Correction of all consolidated ,individual reports for 2021 and the 1st quarter of consolidated report of 2022 attached to the part2 of the financial report
China Chemical & Pharmaceutical : Announced the appointment of the chairman of the board of directors on behalf of the CCPC's important subsidiary "Chunghwa Yuming Healthcare Co., Ltd".
China Chemical & Pharmaceutical : Announced by CCPC on behalf of its subsidiary ,CYH, that its board of directors resolved to re-elect the director
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 1701
  4. Actualités China Chemical & Pharmaceutical Co., Ltd.
  5. Autres langues